Stimulation of Structural and Functional Recovery of the Kidney in Rats with Postischemic Acute Renal Failure of Different Severity by Embryonic Protein-Peptide Complex Therapy

2020 ◽  
Vol 169 (5) ◽  
pp. 623-629
Author(s):  
V. I. Kirpatovskii ◽  
A. V. Sivkov ◽  
S. A. Golovanov ◽  
V. V. Drozhzheva ◽  
G. D. Efremov ◽  
...  
Nephron ◽  
1998 ◽  
Vol 80 (1) ◽  
pp. 41-45 ◽  
Author(s):  
Carmelo Libetta ◽  
Teresa Rampino ◽  
Ciro Esposito ◽  
Alessia Fornoni ◽  
Luca Semeraro ◽  
...  

1994 ◽  
Vol 266 (3) ◽  
pp. F360-F366 ◽  
Author(s):  
N. D. Vaziri ◽  
X. J. Zhou ◽  
S. Y. Liao

Acute renal failure (ARF) is associated with erythropoietin (EPO) deficiency anemia. The present study was designed to determine whether the course of ARF can be altered by preventing EPO deficiency and the associated anemia. Sprague-Dawley rats were injected with a single dose of cisplatin (CP), 7 mg/kg intraperitoneally, and randomized into recombinant EPO-treated (EPO), placebo-treated (control), recombinant EPO-treated pair-fed (EPO-PF), and EPO-treated anemic (EPO-anemic) groups. They were then treated with daily injections of recombinant EPO, 100 U/kg, or placebo for 9 days. Animals in the EPO-anemic group received daily phlebotomies gauged to maintain hematocrits equal to those in the control group. Rats in the EPO-PF group were pair fed with the controls. The control and EPO-anemic groups showed a fall, whereas the EPO and EPO-PF groups showed a rise in hematocrit on day 9. Although blood volume on day 9 was significantly greater in the EPO group than in either the EPO-anemic group or the control group, it was comparable in the latter groups. An equally severe reduction in creatinine clearance (CCr) was found in all groups on day 4. However, measurements of CCr and inulin clearance on day 9 revealed a significantly greater functional recovery in the EPO, EPO-PF, and EPO-anemic groups than in the controls. The enhanced functional recovery with EPO administration was accompanied by an increased tubular regeneration and [3H]thymidine incorporation in the cortical tissue. No significant difference was found in either cortical tissue iron content or arterial blood pressure in the study groups.(ABSTRACT TRUNCATED AT 250 WORDS)


1982 ◽  
Vol 63 (5) ◽  
pp. 30-32
Author(s):  
E. V. Shakhov ◽  
S. A. Kukarin ◽  
V. N. Petrov

Based on the experience of diagnosis and treatment of post-transfusion acute renal failure in 27 surgical patients, the tactics, role and place of hemodialysis in complex therapy are considered. Outcomes and ways to improve treatment outcomes are reported.


2005 ◽  
Vol 83 (3) ◽  
pp. 287-300 ◽  
Author(s):  
Annick Caron ◽  
Richard R Desrosiers ◽  
Stéphanie Langlois ◽  
Richard Béliveau

Although ischemia remains the leading cause of acute renal failure in humans, there is little information on the expression and activities of gelatinases of kidney glomeruli during ischemia–reperfusion injury. In this study, we used a unilateral ischemia–reperfusion model to investigate the activity and expression of gelatinases in glomeruli during acute ischemia. Unilateral ischemia was induced in rats by vascular clamping (30 min) followed by reperfusion (60 min) and isolation of glomeruli. The activity and expression of gelatinase proteins were determined by gelatin zymography and Western blotting. Gelatinase mRNA levels were evaluated by reverse transciptase-PCR. Ischemia and reperfusion increased serum creatinine levels, hallmark of acute renal failure. Ischemia induced mRNA and protein MMP-2 expression. There was strong stimulation of MMP-9 mRNA, both forms of dimeric MMP-9, and active mono meric MMP-9. In contrast to TIMP-1 decreasing, TIMP-2 protein and mRNA increased during ischemia. During reperfusion, there was a gradual reversal of the MMP-2 and MMP-9 levels and a strong inhibition of TIMP-1 and TIMP-2 at the protein and mRNA levels. Endocytic receptor LRP was increased during ischemia and returned to normal during reperfusion. Expression of MMP-9 docking receptor CD-44 was increased during reperfusion. Finally, ZO-1, an in vivo MMP-9 substrate, was degraded during ischemia, revealing that MMP-9 upregulated during ischemia was functional. Our data suggest that stimulation of gelatinase activity during ischemia could contribute to glomeruli injury, providing new therapeutic targets for acute renal failure in humans. In contrast, elevated monomeric MMP-9 activity due to TIMP-1 decrease during reperfusion may participate to glomerular recovery.Key words: gelatinases, ischemia-reperfusion, TIMPs, ZO-1, CD-44, LRP, glomeruli.


Author(s):  
P.A. Oglesby ◽  
K.E. Joubert ◽  
T. Meiring

Amitraz is a formamidine compound used in veterinary medicine as a topical dip to control ticks and mites on dogs and livestock. A 10-year-old female Scottish terrier was presented following the accidental oral administration of a dip containing amitraz. This case report describes the clinical signs, treatment and pathology of this dog. Clinical signs of toxicity from amitraz result from stimulation of alpha2-adrenergic receptors. Amitraz is seldom fatal because the effects can be reversed by alpha2-adrenergic antagonists. The dog recovered from the amitraz toxicity but died 5 days later from acute renal failure.


2016 ◽  
Vol 38 (2) ◽  
Author(s):  
Fernanda Duarte ◽  
Edson Andrade Pessoa ◽  
Luciana Aparecida Reis ◽  
Nestor Schor ◽  
Fernanda Teixeira Borges

Renal Failure ◽  
1994 ◽  
Vol 16 (1) ◽  
pp. 19-26 ◽  
Author(s):  
Armando Luis Negri ◽  
Clarisa Alvarez ◽  
Maria del Carmen Fernandez ◽  
Laura Kane ◽  
Norma Sterin-Speziale ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document